Depression - Major Depressive Disorder
Neurology
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
2027
Verona PharmaHyperbolic tapering
IQVIAReal-world Clinical Response to Trazodone in Italy, Poland, and Romania
Clinical Trials (2)
Total enrollment: 270 patients across 2 trials
Discontination of Antidepressants in Remitted Depression
Start: Feb 2026Est. completion: Sep 2027150 patients
Phase 4Not Yet Recruiting
Real-world Clinical Response to Trazodone in Italy, Poland, and Romania
Start: Dec 2025Est. completion: Jul 2026120 patients
N/ARecruiting
Related Jobs in Neurology
Specialty Account Manager, Symbravo (Queens, NY)
Axsome Therapeutics
Queens, NY
18h ago
$100K - $150K/yr
Specialist Quality Services (Product Complaints)
Sanofi
Hyderabad
Yesterday
Digital Product Lead - iCare Connect
Sanofi
Cambridge, MA
Yesterday
$134K - $193K/yr
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
Yesterday
$208K - $234K/yr
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
Yesterday
Electronics Engineering Manager
CoMind
London, UK
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 270 patients
2 companies competing in this space